Comparison Between Fast-Track and Conventional Anesthesia for Children Undergoing Closure of Ventricular Septal

Mohamad Nour Nasif1, Hidar Alibrahim2, Noheir Ashraf Ibrahem Fathy Hassan3

  • 1Laboratory Medicine, University of Aleppo, Faculty of Medicine, Aleppo, SYR.

Cureus
|December 22, 2023
PubMed

Insights

Fast-track anesthesia for pediatric ventricular septal defect (VSD) closure is safe and effective. This approach significantly reduces healthcare costs, mechanical ventilation, and hospital stays compared to traditional anesthesia.

Area of Science:

  • Pediatric Cardiology
  • Anesthesiology
  • Health Economics

Background:

  • Ventricular septal defect (VSD) is a common congenital heart condition in children.
  • Transthoracic device closure is a standard treatment for pediatric VSD.
  • Optimizing anesthesia protocols is crucial for improving patient outcomes and reducing healthcare burdens.

Purpose of the Study:

  • To evaluate the safety and effectiveness of fast-track anesthesia versus traditional anesthesia in pediatric patients undergoing VSD device closure.
  • To compare operative duration, hemodynamic stability, and resource utilization between the two anesthesia approaches.

Main Methods:

  • Systematic review and meta-analysis adhering to PRISMA guidelines.
  • Inclusion of retrospective observational studies comparing fast-track and conventional anesthesia for pediatric VSD closure.
  • Data extraction and analysis of operative duration, hemodynamic variations, mechanical ventilation, ICU stay, hospitalization, and costs.

Main Results:

  • No significant differences in operative duration or hemodynamic variations between fast-track and conventional anesthesia groups.
  • Fast-track anesthesia group showed significantly reduced mechanical ventilation duration, ICU stay, and overall hospitalization.
  • Healthcare costs were significantly lower in the fast-track anesthesia group (10,000 RMB reduction).

Conclusions:

  • Fast-track anesthesia is a safe and effective strategy for pediatric VSD device closure.
  • This approach leads to substantial reductions in resource utilization and healthcare expenses.
  • Further clinical trials are recommended to validate findings and assess long-term outcomes.